Glucose-Lowering Agents Developed in the Last Two Decades and Their Perioperative Implications
The last two decades have provided far more options f both patients and their physicians in the treatment of diabetes mellitus. While dipeptidyl peptidase-4 inhibitors (DPP-4is) and glucagon-like peptide 1 receptor agonists (GLP-1RAs) have been approved for nearly two decades, sodium–glucose cotrans...
| Hauptverfasser: | , , |
|---|---|
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
MDPI AG
2024-12-01
|
| Schriftenreihe: | Pharmaceuticals |
| Schlagworte: | |
| Online Zugang: | https://www.mdpi.com/1424-8247/18/1/4 |